Theravance Biopharma (TBPH) Accounts Payables (2013 - 2026)
Theravance Biopharma (TBPH) recorded Accounts Payables of $652,000 in Q2 2026, down 61.1% from $1.68 million a year earlier and down 40.7% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Accounts Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Theravance Biopharma reported Accounts Payables of $2.57 million, up 14.5% from FY2024.
- Annual Accounts Payables has a five-year compound annual growth rate of -17.6% (FY2020 to FY2025).
- Across earlier years, Accounts Payables came in at $2.24 million in FY2024 (+47.1%), $1.52 million in FY2023 (-1.9%), $1.55 million in FY2022 (-49.8%) and $3.1 million in FY2021 (-54.3%).
- The Q2 2026 figure is the lowest quarterly Accounts Payables in data going back to Q4 2013.
- On a year-over-year basis, Accounts Payables rose in five of the last eight quarters, with growth averaging 0.3%.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 76.4% in Q1 2023, against a decline of 77.9% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.1 million (Q1 2026), $2.57 million (Q4 2025) and $2.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 652,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 652,000.00 |
| Mar 31, 2026 | 1.10 Mn |
| Dec 31, 2025 | 2.57 Mn |
| Sep 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Dec 31, 2024 | 2.24 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 2.66 Mn |
| Dec 31, 2022 | 1.55 Mn |
| Sep 30, 2022 | 5.34 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | 1.51 Mn |
| Dec 31, 2021 | 3.10 Mn |
| Sep 30, 2021 | 8.90 Mn |
API Access
Theravance Biopharma Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();